Akute intermittierende Porphyrie

Givosiran als neue therapeutische Option

This is a preview of subscription content, access via your institution.

1

Literatur

  1. 1.

    Montgomery D et al. N Engl J Med 2017;377(9):862-72

  2. 2.

    Sardh E et al. N Engl J Med 2019 Feb 7;380(6):549-58

  3. 3.

    G-BA. Arzneimittel-Richtlinie/Anlage XII: Givosiran 15.10.2020

  4. 4.

    Alnylam Netherlands B.V. Fachinformation Givosiran 2020

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Prof. Dr. med. Heiner Wedemeyer or PD Dr. med. Katja Deterding.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wedemeyer, H., Deterding, K. & Tergast, T. Givosiran als neue therapeutische Option. Gastro-News 8, 14–15 (2021). https://doi.org/10.1007/s15036-020-2280-y

Download citation